SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs zooms on receiving zero observation for API facility in Spain

07 Jun 2017 Evaluate

Vivimed Labs is currently trading at Rs. 112.00, up by 6.95 points or 6.62 % from its previous closing of Rs. 105.05 on the BSE.

The scrip opened at Rs. 109.90 and has touched a high and low of Rs. 113.90 and Rs. 109.25 respectively. So far 312164 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 136.40 on 20-Apr-2017 and a 52 week low of Rs. 68.00 on 09-Aug-2016.

Last one week high and low of the scrip stood at Rs. 115.00 and Rs. 104.60 respectively. The current market cap of the company is Rs. 920.71 crore.

The promoters holding in the company stood at 36.48 %, while Institutions and Non-Institutions held 4.68 % and 58.85 % respectively.

Vivimed Labs’ API manufacturing facility located in Sant Celoni, Spain was recently inspected by the US FDA in compliance with their requirements. At the end of the successful inspection, the company has been informed by the investigator that ‘zero 483’ observations were issued. This was a routine inspection by the USFDA.

Recently, the company had inked a definitive agreement with Strides Shasun to grow its presence in the US finished dosage formulation (FDF) business segment.

Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.

Vivimed Labs Share Price

7.38 -0.26 (-3.40%)
21-Apr-2026 12:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.50
Dr. Reddys Lab 1220.50
Cipla 1232.75
Zydus Lifesciences 927.80
Lupin 2321.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×